Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.

MLA

Kodaira, M., et al. “Sorafenib-Induced Erythema Multiforme for Metastatic Renal Cell Carcinoma.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 21, no. 7, July 2010, pp. 1563–65. EBSCOhost, https://doi.org/10.1093/annonc/mdq299.

APA

Kodaira, M., Takahashi, S., Takeuchi, K., Yuasa, T., Saotome, T., Yonese, J., Fukui, I., & Hatake, K. (2010). Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 21(7), 1563–1565. https://doi.org/10.1093/annonc/mdq299

Chicago

Kodaira, M, S Takahashi, K Takeuchi, T Yuasa, T Saotome, J Yonese, I Fukui, and K Hatake. 2010. “Sorafenib-Induced Erythema Multiforme for Metastatic Renal Cell Carcinoma.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 21 (7): 1563–65. doi:10.1093/annonc/mdq299.